Status:

COMPLETED

Beauty Image Efficacy Study

Lead Sponsor:

Pharmanex

Conditions:

Skin Aging

Eligibility:

All Genders

28-55 years

Phase:

NA

Brief Summary

The objective is to evaluate the effects of oral supplement of a blend containing collagen peptides, phosphatidylserine, Saussurea involucrata and lutein (Beauty Image) on the improvement of skin agin...

Eligibility Criteria

Inclusion

  • Facial skin with problems of dull, uneven, inelastic, dryness and wrinkle/fine line (At least fit to two problems)
  • In general good health and good mental state;
  • Willing to read, understand and able to sign the Informed Consent Form;
  • Willing to comply with all study protocol requirements.

Exclusion

  • Intention to become pregnant, pregnant, lactating or within 6 months of delivery;
  • Participation in any clinical test or cosmetic product test on skin within 30 days;
  • Existence of neurodermatitis, pityriasis, seborrheic dermatitis or psoriasis capitis on test area;
  • Use of any anti-inflammatory drugs in the past 2 months;
  • A history of skin diseases such as psoriasis, eczema, psoriasis, skin cancer, etc.;
  • IDDM: Insulin dependent diabetic patients;
  • Current treatment for asthma or other chronic respiratory diseases;
  • Undergoing anticancer chemotherapy in the past 6 months;
  • Existence of any other health problems or chronic diseases;
  • Use of retinoids, alpha hydroxyl acid, ortho-hydroxybenzoic acid, hydroquinone nearly within 3 months; or use of prescriptions (such as antibiotics, retinoids, alpha hydroxyl acid or steroids), oral contraceptives (Use of same contraceptives for 6 months excepted);
  • Existence of the following conditions or factors that the Investigator believes may affect the response of the skin or the interpretation of the test results, including, but not limited to, diabetes, vascular disease, hepatitis, eczema, psoriasis.

Key Trial Info

Start Date :

May 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2018

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04733755

Start Date

May 1 2018

End Date

September 1 2018

Last Update

February 2 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nu Skin (China) Daily-use & Health Products CO., LTD

Shanghai, Shanghai Municipality, China